We are live on ! Find out more
ICU icon

SeaStar Medical

8 hedge funds and large institutions have $4.82M invested in SeaStar Medical in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.32% less ownership

Funds ownership: 0.37%0.04% (-0.32%)

83% less funds holding

Funds holding: 488 (-40)

91% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 44

95% less capital invested

Capital invested by funds: $98M → $4.82M (-$93.2M)

Holders
8
Holders Change
-40
Holders Change %
-83.33%
% of All Funds
0.13%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
2
Reduced
2
Closed
44
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
51
Difesa Capital Management
New York
-$163K -63 Closed
RA
52
RiverPark Advisors
New York
-$136K -53 Closed
SSA
53
Schonfeld Strategic Advisors
New York
-$109K -43 Closed
SOA
54
Sea Otter Advisors
Florida
-$70K -27 Closed

ICU Hedge Fund Activity: Q4 2022 in Review

8 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q4 2022, worth a combined $4.82M — down 95% from $98M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of ICU and 4 opened new positions — a net loss of 40 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Cohen & Co Financial Management, opening a new position worth an estimated $4.05M. The largest seller was Karpus Investment Management, exiting entirely with an estimated $15.1M sold.

  • 8 institutional investors held SeaStar Medical (ICU) as of Q4 2022, down from 48 in Q3 2022.
  • Funds reported $4.82M of SeaStar Medical stock for Q4 2022, down 95% quarter-over-quarter.
  • 4 funds opened new SeaStar Medical positions in Q4 2022 and 44 closed out, a net change of -40 holders.
  • The largest SeaStar Medical buyer in Q4 2022 was Cohen & Co Financial Management, an estimated $4.05M added.
  • The largest SeaStar Medical seller in Q4 2022 was Karpus Investment Management, an estimated $15.1M sold.

Based on aggregated 13F filings for Q4 2022.